IndiaInfoline » Markets » NATCOPHARM

Natco Pharma Ltd - Share Price

NATCOPHARM

Open

570.65

Prev. Close

565.65

Turnover (lac.)

390

Day's High

578.00

Day's Low

565.00

52 Week's High

799.90

52 Week's Low

480.00

Book Value

204

Face Value

2

Mkt Cap (Cr.)

10,443

P/E

16.38

EPS

34.43

Divi. Yield

1.12

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd401.5043.7695,853.43763.370.693,020.4995.21
Divis Laboratories Ltd1,722.9534.2745,709.71267.350.931,139.92262.68
Dr Reddys Laboratories Ltd2,727.4029.9944,872.64548.100.742,497.60766.66
Cipla Ltd446.3016.4235,995.39694.000.673,126.21195.79
Lupin Ltd726.5019.6333,147.38445.930.682,878.91378.16

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

No Company Summary found

Registered Office

Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033

Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in

Registrar Office

12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA

Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com

View

- <

Reco. Price

Oct 01,2019 10:29 AM

Target Price

Target Returns:

0.00%

Result Express

Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates

Oct 17, 2019 04:39 PM

The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    AGM

    Exp. Date

    05 Sep 2019

    Annc. Date

    09 Aug 2019

    AGM 05/09/201936th Annual Report for the year 2018-19Book Closure from 3rd September 2019 to 5th Sep... More

  • Purpose

    Dividend

    Annc. Date

    09 Aug 2019

    Effective. Date

    22 Aug 2019

    Divi. Type

    Interim

    Divi.(%)

    62.5

    Divi. Amt.

    1.25

    Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at their meeting held o... More

  • Purpose

    Board Meeting

    Exp. Date

    09 Aug 2019

    Annc. Date

    31 Jul 2019

    NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More